BBC catches up with Optician

I was interested to see a story on the BBC's website about the use of Avastin to treat AMD

 As readers of Optician will know this is a story that we have been following for sometime. Those we speak to about this issue are generally very cautious about naming the drug companioes involved. The implication could be read that drug companies are denying patients eyecare by not licencsing the drug for occular use.

 If the ways in which the different forms of the drug were changed not as much money would be made, say critics.